Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1441-1450 of 9367

Page
per page
  1. LDN 209929 dihydrochloride
    B7785 LDN 209929 dihydrochloride
    Target: haspin kinase
    Summary: haspin kinase inhibitor
      <40.58 mg/mL
  2. TRAM 39
    B7786 TRAM 39
    Summary: Potent KCa3.1 blocker
      <15.44 mg/mL
  3. PMX 205 Trifluoroacetate
    B7787 PMX 205 Trifluoroacetate
    Target: C5a receptors
    Summary: C5a receptor peptide antagonist
      ≥97.8 mg/mL
  4. MPC 6827 hydrochloride
    B7788 MPC 6827 hydrochloride
    Summary: Potent microtubule inhibitor
      ≥10.55 mg/mL
  5. Huwentoxin XVI
    B7789 Huwentoxin XVI
    Summary: N-type Ca2+ channel blocker,potent and selective
      Soluble to 1 mg/mL
  6. UC 112
    B7790 UC 112
    Summary: IAP inhibitor
      Soluble in DMSO
  7. 6-Bnz-cAMP sodium salt
    B7791 6-Bnz-cAMP sodium salt
    Summary: cAMP analog,PKA activator
      Soluble in H2O
  8. AH 7614
    B7792 AH 7614
     1 Citation
    Target: Free Fatty Acid Receptors
    Summary: FFA4/GPR120 antagonist
      ≥35.1 mg/mL
  9. GSK 137647
    B7793 GSK 137647
    Summary: FFA4/GPR120 agonist
      insoluble in H2O; ≥121.6 mg/mL
  10. BMS 309403
    B7794 BMS 309403
     5 Citation
    Target: Fatty-acid-binding proteins (FABPs)
    Summary: FABP4 inhibitor,potent and selective
      insoluble in H2O; ≥18.15 mg/mL

Items 1441-1450 of 9367

Page
per page